A rare case of early-onset lymphomatoid papulosis refractory to brentuximab vedotin

Dermatol Ther. 2021 May;34(3):e14943. doi: 10.1111/dth.14943. Epub 2021 Mar 18.

Authors

Martina Ferranti¹, Roberto Salmaso², Dario Marino³, Mauro Alaibac¹

Affiliations

¹ Unit of Dermatology, Department of Medicine-DIMED, University of Padova, Padova, Italy.
² Pathology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
³ Oncology Unit, Istituto Oncologico Veneto-IRCCS, Padova, Italy.

PMID: 33719147
DOI: 10.1111/dth.14943

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Brentuximab Vedotin
Humans
Immunoconjugates*
Ki-1 Antigen
Lymphomatoid Papulosis* / diagnosis
Lymphomatoid Papulosis* / drug therapy

Substances

Immunoconjugates
Ki-1 Antigen
Brentuximab Vedotin